Clinical Trials Browser

Phase 1 × Has results × Immunoglobulin Light-chain Amyloidosis × Clear all

NCT01318902 2020-04-01

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

Phase 1 Completed

27 enrolled 34 charts

Immunoglobulin Light-chain Amyloidosis

NCT02603172 2019-09-23

A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis

Phase 1 Terminated

23 enrolled 25 charts

Immunoglobulin Light-chain Amyloidosis, Amyloidosis